Table 1.
Clinical characteristics of proband included in the study.
| Characteristics | N (%) |
|---|---|
| Total | 36 |
| Gender | |
| Male | 18 (50) |
| Female | 18 (50) |
| Age (years) | 44 (range: 22–68) |
| ≤ 29 | 7 (19) |
| 30–39 | 7 (19) |
| 40–49 | 12 (33) |
| 50–59 | 4 (11) |
| 60 or older | 6 (16) |
| Smoking status | |
| Current smoker | 16 (44) |
| Previously smoker | 3 (8) |
| Non smoker | 17 (47) |
| Stage | |
| I | 5 (14) |
| II | 6 (17) |
| III | 12 (33) |
| IV | 13 (36) |
| Family history of gastric cancer * | |
| 1 family member (only proband) | 17 (47) |
| 2 family members | 6 (17) |
| 3 family members | 9 (25) |
| 4 or more family members | 4 (11) |
| Family history of breast cancer | 6 (16) |
| Family history of colorectal cancer | 2 (6) |
| Family history of prostate cancer | 3 (8) |
| Family history of uterine cancer | 2 (6) |
| Family history of skin cancer | 1 (3) |
| Family history of esophageal cancer | 1 (3) |
| Family history of gallbladder cancer | 1 (3) |
| Family history of lung cancer | 1 (3) |
| Family history of thyroid cancer | 1 (3) |
| Family history of ovarian cancer | 1 (3) |
| Family history of other cancer unknown | 6 (16) |
| Helicobacter pylori infection | |
| Infected | 15 (42) |
| Not infected | 10 (28) |
| Unknown | 11 (30) |
* Including proband and first and second-degree family members.